Verdict Boosts Amgen
Stock quotes in this article:
AMGN
A jury voted in favor of Amgen(AMGN Quote) Tuesday in a patent dispute case, according to a Bloomberg report.
The ruling determines in effect that Roche may not sell Mircera, its rival medicine to Amgen's Aranesp and Epogen anemia drugs, in the U.S. Amgen shares were rising 87 cents, or 1.6%, to $56.99 in recent trading.- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
Connect with TheStreet
 |
 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,328.89 | 1,102.47 | 2,211.69 | 35.46 |
Oil *
73.88
|
|
UP
20.63
|
UP
6.40
|
UP
31.64
|
UP
0.59
|
10 Yr
3.55%
SPDR Gold
108.95
|
|
+0.20%
|
+0.58%
|
+1.45%
|
+1.69%
|
Data delayed 20 minutes |
